RALPH BURROUGHS: Open Payments
NPI 1760674949 · GULFPORT, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$573 in 24 payments from 8 companies in 2025. Trend: 2023 $498 · 2024 $393 · 2025 $573
Food & beverage: $573
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $170 |
| E.R. Squibb & Sons, L.L.C. | 5 | $115 |
| Axsome Therapeutics, Inc. | 1 | $95 |
| Alkermes, Inc. | 2 | $52 |
| Otsuka America Pharmaceutical, Inc. | 2 | $50 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $40 |
| Teva Pharmaceuticals USA, Inc. | 1 | $27 |
| Lundbeck LLC | 1 | $24 |
Products named: VRAYLAR, COBENFY, Auvelity, ARISTADA, ABILIFY ASIMTUFII, CAPLYTA, ABILIFY MAINTENA, AUSTEDO XR.
Industry payments across MS — which companies pay providers there.
